Long-term outcomes following stereotactic body radiotherapy boost for oropharyngeal squamous cell carcinoma

Acta Oncologica
Sarah BakerWilma D Heemsbergen

Abstract

Background/purpose: To determine the efficacy and toxicity profile of a stereotactic body radiotherapy (SBRT) boost as a first line treatment in patients with oropharyngeal squamous cell carcinoma (OPSCC). Materials and methods: We performed a retrospective cohort study in 195 consecutive OPSCC patients with T1-small T3 disease, treated at Erasmus MC between 2009 and 2016 with a SBRT (3 × 5.5 Gy) boost after 46 Gy IMRT. Primary endpoints were disease-specific survival (DSS) and Grade ≥3 toxicity (Common Terminology Criteria). The Kaplan-Meier method and Cox regression model were applied to determine rates and risk factors. Results: The median follow-up was 4.3 years. Treatment compliance was high (100%). Rates of 5-year DSS and late grade ≥3 toxicity were 85% and 28%, respectively. Five-year overall survival was 67%. The most frequently observed toxicities were mucosal ulceration or soft tissue necrosis (n = 30, 5 year 18%), dysphagia or weight loss (n = 18, 5 year 12%) and osteoradionecrosis (n = 11, 5 year 9%). Current smoker status (hazard ratio [HR] = 2.9, p = .001) and Charlson Comorbidity Index ≥2 (HR = 1.9, p = .03) were was associated with increased toxicity risk. Tooth extraction prior to RT was associated with increas...Continue Reading

References

Jul 15, 1992·The American Journal of Medicine·P Silverstein
Jan 1, 1991·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·G H Fletcher
Jun 9, 2004·International Journal of Radiation Oncology, Biology, Physics·Ugur SelekK Kian Ang
Jan 1, 2008·International Journal of Radiation Oncology, Biology, Physics·Wendy HaraQuynh-Thu Le
May 13, 2008·International Journal of Radiation Oncology, Biology, Physics·David N TeguhPaul I M Schmitz
Aug 15, 2008·The Oncologist·Gregory RussoMitchell Machtay
Mar 31, 2009·International Journal of Radiation Oncology, Biology, Physics·Farzan SiddiquiSamuel Ryu
Jun 23, 2009·International Journal of Radiation Oncology, Biology, Physics·Avraham EisbruchK Kian Ang
Apr 20, 2010·International Journal of Radiation Oncology, Biology, Physics·Allen M ChenSrinivasan Vijayakumar
Jun 10, 2010·The New England Journal of Medicine·K Kian AngMaura L Gillison
Aug 3, 2010·International Journal of Radiation Oncology, Biology, Physics·Mustafa CengizFadil Akyol
Dec 4, 2010·Journal of Radiation Research·Naohiro KodaniTsunehiko Nishimura
Jun 7, 2012·Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology·Syed Nabil, Nabil Samman
Jul 17, 2012·International Journal of Radiation Oncology, Biology, Physics·Chiaojung Jillian TsaiLei Dong
Feb 12, 2013·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Abrahim Al-MamganiRob J Baatenburg de Jong
Mar 6, 2015·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Sarah E PeknyReza Shadmehr
Apr 14, 2015·British Journal of Cancer·L J MelchersE Schuuring
Mar 8, 2017·Journal of Oncology Practice·Kimberly ThomasDavid L Schwartz

❮ Previous
Next ❯

Citations

Jan 15, 2022·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Panagiotis BalermpasIlja F Ciernik

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.